William Blair has recently initiated Elevation Oncology Inc (ELEV) stock to Outperform rating, as announced on January 3, 2025, according to Finviz. Earlier, on May 31, 2024, Piper Sandler had ...
"The combination of these factors makes rates the most important variable to watch in early 2025, in our view," Wilson wrote. Higher rates are seen as a headwind for equities, particularly in more ...